IV-361

CAT: 0804-HY-139011-01Size: 5 mgDry Ice: NoHazardous: No

CAT#:0804-HY-139011-01Size:5 mg

Selected

PRICE

AVAILABILITY: InStock

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

1 / 1

Description

IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM) . IV-361 has anti-cancer activity (US20190256531A1) [1].

CAS Number

[2055741-39-2]

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

COVID-19-anti-virus

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/iv-361.html

Purity

99.60

Solubility

DMSO : 90 mg/mL (ultrasonic)

Smiles

O=C(N(C1)C(C)(C)C2=C1C(NC(C3([Si](C)(C)C)CCC3)=O)=NN2)NC4=CC(F)=CC=C4C

Molecular Formula

C23H32FN5O2Si

Molecular Weight

457.62

References & Citations

[1]Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CDK2; CDK7

Related Products

Catalog	Name
HY-111187-01	KX2-361
HY-121422-01	JZP-361
HY-W953311	CRBN ligand-361
HY-P3713	Presenilin 1 (349-361)
HY-RI04442-01	Rno-miR-361-3p inhibitor
HY-R04442-01	Rno-miR-361-3p mimic
HY-R03092A-01	Mmu-miR-361-3p agomir
HY-RI04442A-01	Rno-miR-361-3p antagomir
HY-R04442A-01	Rno-miR-361-3p agomir
HY-RI03092-01	Mmu-miR-361-3p inhibitor

Alternative Products

Catalog	Name
T39456-01	IV-361
M34301-01	JZP-361
M16453-01	KX2-361
MBS201027-01	G-361
J212015	JZP 361
C0006051	MDA-MB-361

IV-361

Related Products

Alternative Products

Popular Products